###begin article-title 0
###xml 116 120 <span type="species:ncbi:10090">mice</span>
Accumulation of marginal zone B cells and accelerated loss of follicular dendritic cells in NF-kappaB p50-deficient mice
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 732 736 <span type="species:ncbi:10090">mice</span>
Marginal zone (MZ) B cells play important roles in the early phases of humoral immune responses. In addition to possessing an inherent capacity to rapidly differentiate into antibody secreting cells, MZ B cells also help to regulate the fate of both T-independent and T-dependent blood-borne antigens in the spleen. For T-dependent antigens, MZ B cells bind IgM-antigen complexes in a complement-dependent manner. Once MZ B cells bind IgM-containing immune complexes (IgM-IC), they transport them into B cell follicles for deposition onto follicular dendritic cells (FDCs), an important component of secreted IgM's ability to enhance adaptive immune responses. To further define the requirement for MZ B cells in IgM-IC deposition, mice deficient in the NF-kappaB protein p50, which have been reported to lack MZ B cells, were analyzed for their ability to trap IgM-IC onto FDCs.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 203 211 203 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 215 223 215 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 285 289 285 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 506 510 506 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 539 543 539 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 755 759 755 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
Mice (2 months of age) deficient in p50 (p50-/-) had small numbers of MZ B cells, as determined by cell surface phenotype and localization in the splenic MZ. These cells bound high levels of IgM-IC both in vivo and in vitro. Subsequent to the binding of IgM-IC by the MZ B cells in p50-/- mice, small amounts of IgM-IC were found localized on FDCs, suggesting that the MZ B cells retained their ability to transport these complexes into splenic follicles. Strikingly, MZ B cells accumulated with age in p50-/- mice. By 6 months of age, p50-/- mice contained normal numbers of these cells as defined by CD21/CD23 profile and high level expression of CD1d, CD9, and IgM, and by their positioning around the marginal sinus. However, FDCs from these older p50-/- mice exhibited a reduced capacity to trap IgM-IC and retain complement components.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 199 203 <span type="species:ncbi:10090">mice</span>
These results demonstrate that while the p50 component of the NF-kappaB transcription complex plays an important role in the early development of MZ B cells, MZ B cells can develop and accumulate in mice lacking this protein. These results highlight the interface between genetic deficiencies and age, and suggest that different transcription factors may play distinct roles in the development and maintenance of cell populations at different ages.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 350 351 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 352 353 352 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
Secreted IgM antibodies play important roles in the initial phases of humoral immune responses. Unlike other antibody isotypes, secreted IgM uniquely functions as an adjuvant, promoting primary antibody responses to sub-immunogenic doses of T-dependent antigens [1-7]. The adjuvanticity of IgM is completely dependent on an intact complement system [7-9]. While mice deficient in secreted IgM make protective antibody responses to pathogens, these responses are delayed compared to the immune response of IgM sufficient mice [10-13] Interestingly, pathogens more readily disseminate into vital organs in secreted IgM-deficient mice, rather than concentrate them into secondary lymphoid organs [14]. This suggests that an important role for IgM is to serve as an arbiter of antigen localization, which may contribute to its adjuvant function(s).
###end p 9
###begin p 10
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1215 1217 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 669 673 <span type="species:ncbi:10090">mice</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
###xml 965 969 <span type="species:ncbi:10090">mice</span>
###xml 1015 1019 <span type="species:ncbi:10090">mice</span>
To investigate how IgM affects the localization of foreign antigen, a system was developed to follow the fate of IgM-containing immune complexes (IgM-IC) following their intravenous (i.v.) administration [7,15] IgM-IC first localize to the splenic marginal zone (MZ), where they are phagocytized by MZ macrophages and are also bound to MZ B cells. Binding of IgM-IC to MZ B cells is strictly complement dependent. The MZ B cells subsequently transport the IgM-IC into the B cell follicles where they are deposited onto follicular dendritic cells (FDCs) [15]. The important role of MZ B cells in this process was established by monitoring IgM-IC deposition onto FDCs in mice that lacked MZ B cells, either as a result of a genetic lesion (CD19-deficient mice) that inhibited MZ B cell survival, or by their depletion using pertussis toxin. In these mice, little if any IgM-IC was deposited onto FDCs. In addition, adoptive transfer of B cells with bound IgM-IC into mice led to IgM-IC deposition onto FDCs. In these mice, transferred MZ B cells in close proximity to FDCs were found to have IgM-IC capped and directed toward the FDC dendrites, strongly suggesting IgM-IC was being transferred to FDCs by MZ B cells [15].
###end p 10
###begin p 11
###xml 157 159 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 354 356 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 434 438 426 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 505 513 497 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 517 525 509 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 593 597 585 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 696 700 688 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
###xml 700 704 <span type="species:ncbi:10090">mice</span>
###xml 1000 1004 <span type="species:ncbi:10090">mice</span>
To further investigate the role of MZ B cells in IgM-IC transport, we used mice deficient in p50, a member of the NF-kappaB family of transcription factors [16]. These mice have been reported to lack MZ B cells, suggesting an unambiguous role for this component of the NF-kappaB transcription factor complex in the development of this subset of B cells [17]. However, we found that small numbers of MZ B cells are present in young p50-/- mice, and these cells are capable of binding high levels of IgM-IC in vivo and in vitro. Interestingly, MZ B cells were found to accumulate with age in p50-/- mice such that by 6 months a normal sized MZ B cell compartment was present. We also found that p50-/- mice exhibited an accelerated loss of FDC networks, as assessed by intense CD21 staining. These data indicate that MZ B cells can develop in the complete absence of p50, and suggest that the transcriptional requirements for the development and/or survival of MZ B cells might differ in young and old mice.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Presence of MZ B cells in p50-deficient mice
###end title 13
###begin p 14
###xml 17 21 17 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 159 163 159 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 448 452 448 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 465 466 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 530 534 530 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 766 770 766 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
Two month old p50-/- or control C57BL/6 (B6) mice were injected with IgM-IC and the spleens removed 16 h later. Based on the reported lack of MZ B cells in p50-/- mice [17] and the requirement for MZ B cells in the transport and deposition of IgM-IC onto FDCs [15], we expected that IgM-IC would not be found localized on FDCs in the splenic follicles of these mice. However, immunohistochemistry (IH) revealed the presence of IgM-IC on FDCs in p50-/- mice (Figure 1). The amount of IgM-IC localized in the spleen follicles of p50-/- mice was substantially less than in control B6 mice, but none-the-less readily detectable. These results could indicate either that IgM-IC can traffic to FDCs by a previously unanticipated mechanism independent of MZ B cells, or p50-/- mice may possess small numbers of MZ B cells that are still functional for transporting IgM-IC into follicles.
###end p 14
###begin p 15
###xml 73 77 73 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 300 301 300 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 361 365 361 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 425 427 425 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 432 435 432 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo </sup>
###xml 443 444 443 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 449 452 449 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi </sup>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1037 1039 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1130 1134 1130 1134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1307 1309 1307 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1352 1355 1352 1355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi </sup>
###xml 1366 1370 1366 1370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1483 1492 1483 1492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1515 1517 1515 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1528 1532 1528 1532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1567 1575 1567 1575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
###xml 778 782 <span type="species:ncbi:10090">mice</span>
###xml 1134 1138 <span type="species:ncbi:10090">mice</span>
###xml 1259 1263 <span type="species:ncbi:10090">mice</span>
###xml 1370 1374 <span type="species:ncbi:10090">mice</span>
###xml 1738 1742 <span type="species:ncbi:10090">mice</span>
To help discriminate between these alternatives, splenic B cells from p50-/- mice were analyzed for the presence of MZ B cells by FACS. MZ B cells can be phenotypically distinguished from other B cell subsets in the spleen based on CD21/23 [18,19] and B220/CD1d [20,21]. profiles. As shown in Figure 2, MZ B cells were, as expected [17], severely reduced in p50-/- mice. However, small numbers of B cells fell within the CD21hi/CD23lo and B220+/CD1dhi gates, at ~10% of the frequency found in the B cell compartment of control B6 mice. To determine if these MZ B cells could bind high levels of IgM-IC, spleen cells from mice that had been injected 1 h earlier were isolated and the presence of IgM-IC on B cell subsets was determined by FACS. When IgM-IC were injected into B6 mice, the complexes were found associated with MZ B cells at high levels (Figure 2A), as expected from their high level expression of the complement receptor CR2 (CD21) and localization at the marginal sinus, which facilitates exposure to blood-borne IgM-IC [15]. In contrast, little if any of the IgM-IC were present on follicular (FO) B cells. In p50-/- mice, there was discernable binding of IgM-IC to MZ B cells (as defined by a shift in the FACS profile) while, as seen in B6 mice, IgM-IC did not bind to FO B cells (Figure 2A). This suggests that the cells in the CD21hi gate in p50-/- mice were authentic MZ B cells. To confirm this, the capacity of these cells to bind IgM-IC was determined using in vitro binding assays (Figure 2B). When p50-/- B cells were incubated with IgM-IC in vitro, MZ B cells bound higher levels of IgM-IC than did FO B cells (3 to 5 times as assessed by mean fluorescence intensity), similar to results using B cells from B6 mice.
###end p 15
###begin p 16
###xml 28 32 28 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 72 74 72 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 78 81 78 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo </sup>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 297 299 297 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
Note that the spleens of p50-/- mice contain an increased number of CD21loCD23lo B cells (Fig. 2A; see also Fig. 3A). While we have not explored the identity of these cells in detail. they are likely to reflect increased numbers of immature "transitional" B cell subsets, since the number of AA4.1+ B cells [22] in the spleens of these mice are increased (up to 2-fold) over those in age-matched control B6 mice. As expected from their low levels of CD21, however, this population of cells does not bind IgM-IC (data not shown).
###end p 16
###begin p 17
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi </sup>
###xml 133 137 133 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 397 400 397 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi </sup>
###xml 460 462 460 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 484 487 484 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi </sup>
###xml 547 551 547 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 706 710 706 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
###xml 644 648 <span type="species:ncbi:10090">mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
MZ B cells can be distinguished as IgMhi B cells positioned outside of the marginal sinus. To determine whether the MZ B cells in p50-/- mice were positioned correctly around the marginal sinus of the spleen, immunofluorescence (IF) was performed on spleen sections using anti-IgM and anti-MOMA-1, which stains marginal metallophilic macrophages and delineates the MZ [23]. In control B6 mice, IgMhi cells (in red) were present in the MZ, outside of the MOMA-1+ cells (Figure 2C). IgMhi MZ B cells were also found outside of the MOMA-1 ring in p50-/- mice, but in reduced numbers, as expected from the drastic reductions in MZ B cells in these mice (Figure 2A). Taken together, these data indicate that p50-/- mice contain small numbers of MZ B cells that are correctly positioned around the marginal sinus, where they can encounter blood-borne IgM-IC and transport them into splenic follicles for deposition onto FDCs.
###end p 17
###begin title 18
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Accumulation of MZ B cells with age in p50-deficient mice
###end title 18
###begin p 19
###xml 14 18 14 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 148 152 148 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 683 687 683 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 900 902 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 1060 1062 1060 1062 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1067 1070 1067 1070 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo </sup>
###xml 1156 1158 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1169 1171 1169 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1207 1209 1207 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1230 1232 1230 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1249 1252 1249 1252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi </sup>
###xml 1259 1262 1259 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi </sup>
###xml 1292 1296 1292 1296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1478 1480 1478 1480 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1484 1487 1484 1487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo </sup>
###xml 1566 1568 1566 1568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1590 1594 1590 1594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1734 1736 1734 1736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1794 1798 1794 1798 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1811 1813 1811 1813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 1851 1853 1851 1853 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1922 1924 1922 1924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 558 562 <span type="species:ncbi:10090">mice</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
###xml 1296 1300 <span type="species:ncbi:10090">mice</span>
###xml 1426 1430 <span type="species:ncbi:10090">mice</span>
###xml 1594 1598 <span type="species:ncbi:10090">mice</span>
###xml 1673 1677 <span type="species:ncbi:10090">mice</span>
###xml 1721 1725 <span type="species:ncbi:10090">mice</span>
###xml 1798 1802 <span type="species:ncbi:10090">mice</span>
When older p50-/- mice were analyzed for the presence of MZ B cells, increased frequencies of MZ B cells were detected. At 4 months of age, some p50-/- mice contained increased numbers of MZ B cells, whereas others did not, suggesting that these cells might be emerging around this time period (data not shown). By 6 months of age, a phenotypically distinct MZ B cell population was detected in all of the more than 10 mice analyzed, as determined by the CD21/23 profile. In these mice, MZ B cells were present at frequencies comparable to those found in B6 mice (Figure 3A, left panels), although the total number of splenic B cells did not appear to change. At all ages tested, p50-/- and B6 mice had similar frequencies of T and B cells in their spleens, and their spleen sizes were also similar (unpublished results), and the cellularity of the spleens (as determined by IH; see for example Fig. 5B) were also similar, indicating that the increased number of MZ B cells was selective for this subset of cells. To confirm the phenotypic identity of the CD21hi/CD23lo B cells as MZ B cells, the expression of other markers of MZ B cells, including CD1d [20] and CD9 [24], was assessed. As shown in Figure 4A, populations of B220+ B cells with CD1dhi and CD9hi phenotypes were present in p50-/- mice, consistent with the presence of MZ B cells. The frequencies of these cells were similar to those in aged-matched control B6 mice. We also assessed the levels of IgM on the CD21hiCD23lo cells, since MZ B cells express higher levels of IgM compared with FO B cells [25]. MZ B cells from p50-/- mice clearly expressed higher levels of IgM than on FO B cells from these same mice, and at levels similar to those in control mice (Figure 4B). These B cells were also positioned within the MZ in p50-/- mice (Figure 4C), as indicated by the presence of IgM+ cells outside of the marginal sinus as revealed by laminin staining [26].
###end p 19
###begin p 20
###xml 128 136 128 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 140 148 140 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 215 219 215 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 343 352 343 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 423 427 423 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 585 589 585 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
As further evidence that the accumulating cells were functional MZ B cells, cells were tested for their capacity to bind IgM-IC in vivo and in vitro. MZ B cells from 2 and 6 month old B6 mice or from 6 month old p50-/- mice had high levels of IgM-IC bound following i.v. injection, whereas FO B cells bound little or no IgM-IC (Figure 3A). An in vitro binding assay also demonstrated the capacity of the MZ B cells from p50-/- mice to bind high levels of IgM-IC compared to FO B cells (Figure 3B). Taken together, the data demonstrate that while few MZ B cells are present in young p50-/- mice, they do develop and accumulate with age, such that by 6 months they have reached normal levels and can functionally bind IgM-IC at high levels, as would be expected from their increased expression of CR1/2 (CD21/35).
###end p 20
###begin title 21
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Accelerated loss of FDC networks in p50-deficient mice
###end title 21
###begin p 22
###xml 63 67 63 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 311 315 311 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 837 841 837 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 888 890 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 964 968 964 968 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1139 1141 1139 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 1213 1215 1213 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 1318 1320 1318 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1368 1372 1368 1372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1481 1482 1481 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1520 1522 1520 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1574 1576 1574 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 841 845 <span type="species:ncbi:10090">mice</span>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
###xml 968 972 <span type="species:ncbi:10090">mice</span>
###xml 1074 1078 <span type="species:ncbi:10090">mice</span>
###xml 1200 1204 <span type="species:ncbi:10090">mice</span>
###xml 1379 1383 <span type="species:ncbi:10090">mice</span>
###xml 1468 1472 <span type="species:ncbi:10090">mice</span>
###xml 1644 1648 <span type="species:ncbi:10090">mice</span>
###xml 1760 1764 <span type="species:ncbi:10090">mice</span>
###xml 1850 1854 <span type="species:ncbi:10090">mice</span>
In an effort to determine whether the repopulation of older p50-/- mice with MZ B cells enabled efficient IgM-IC trapping, mice were injected with IgM-IC and analyzed for FDC deposition. Despite the normal levels and positioning of MZ B cells, no IgM-IC deposition was observed in the spleens of 6 month old p50-/- mice (Figure 5A). The failure of the IgM-IC to localize in the follicles of these mice could be due to the absence of FDCs. However, as shown in Figure 5B, FDCs were present in these mice, as assessed by CD21 staining. However, they appeared to be much smaller and the dendrites less pronounced than in age-matched B6 mice, as evident from the diminished area of intense CD21 staining (Figure 5B, right panels; see arrows). In addition, the number of follicles with intense CD21 staining was reduced in the 6 month old p50-/- mice compared with age matched B6 mice (Figure 5B, 4x view in left panels). This suggests that the ability of FDCs from p50-/- mice to retain complement fragments might be diminished at 6 months of age. Interestingly, 6 month old B6 mice also exhibited some reduced capacity to trap IgM-IC (Figure 5A) and slightly reduced CD21 staining compared with younger mice (Figure 5B), suggesting a loss of FDC function may also be occurring naturally with age, as previously observed [27]. Consistent with this, FDCs in 6 month old p50-/- and B6 mice could not be detected by FDC-M2 staining (data not shown), in contrast with younger mice (Figure 1). FDC-M2 is a FDC specific antibody [28] that detects the complement component C4 on FDCs [29]. The data indicate the loss of FDC function may be accelerated in mice lacking p50. Together, the data imply that the lack of FDC localization of IgM-IC in 6 month old p50-deficient mice is not due to functional inactivity of the MZ B cells that have accumulated in these mice, but reflects a loss of FDCs and/or FDC function by this age.
###end p 22
###begin title 23
Discussion
###end title 23
###begin p 24
###xml 45 49 41 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 378 382 374 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 484 486 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 557 561 553 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 638 640 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 802 806 798 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 990 992 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1025 1029 1021 1025 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1130 1132 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1179 1183 1175 1179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1243 1245 1239 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1387 1391 1383 1387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1619 1623 1615 1619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 2044 2046 2032 2034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 2047 2049 2035 2037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 2196 2198 2184 2186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 2199 2201 2187 2189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 2291 2293 2279 2281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 2396 2398 2381 2383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 2444 2448 2429 2433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 2694 2698 2679 2683 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 2828 2830 2813 2815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 2987 2991 2972 2976 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
###xml 1029 1033 <span type="species:ncbi:10090">mice</span>
###xml 1391 1395 <span type="species:ncbi:10090">mice</span>
###xml 1623 1627 <span type="species:ncbi:10090">mice</span>
###xml 2448 2452 <span type="species:ncbi:10090">mice</span>
###xml 2698 2702 <span type="species:ncbi:10090">mice</span>
###xml 2991 2995 <span type="species:ncbi:10090">mice</span>
Our data demonstrate that while NF-kappaB p50-/- mice are clearly deficient in MZ B cells for the first 2 months of life, MZ B cells appear with age, such that by 6 months a normal splenic MZ B cell compartment has been reconstituted. There are at least four distinct but not mutually exclusive mechanisms that could account for the late appearance of cells within the MZ of p50-/- mice. First, these B cells could be memory B cells, which have been reported to accumulate in the MZ [30]. While we cannot formally rule out this possibility, B cells from p50-/- mice respond poorly to antigenic challenge, especially T-dependent antigens [16]. Consequently, it is unlikely that memory B cells would be generated in these mice, irrespective of their age. Alternatively, the emergence of MZ B cells in p50-/- mice could represent the accumulation of these cells through homeostatic proliferation, in which cells proliferate to fill niches in response to deficits in specific subsets of cells [31]. While splenic B cells from p50-/- mice will undergo homeostatic proliferation as a consequence of their transfer into SCID recipients [32], the ability of the few MZ B cells in the p50-/- donor spleen to expand following transfer was not examined [32]. Nevertheless, we view it as unlikely that homeostatic proliferation accounts for the accumulation of MZ B cells in the spleens of older p50-/- mice, since the accumulation of cells brought on by homeostatic proliferation is generally observed over a much shorter period of time, days to a couple of weeks, rather than the months required to reconstitute MZ B cells in p50-/- mice. A third possibility is that a NF-kappaB p50-dependent signal transduction pathway that activates a developmentally required transcription program in MZ B cells or their precursors is overcome by compensatory mechanisms with aging. NF-kappaB p50 is involved in a number of pathways crucial for B cell development and maturation, including B cell receptor (BCR) signalling and responses to members of the TNF family [33-35] Signal strength through the BCR has been proposed to be an important determinant of B cell lineage fate decisions, including the MZ B cell pool [36,37] BAFF signalling is also important for the selection of B cells into the MZ B cell pool [38], while an intact LT-beta R signalling pathway is required for the proper positioning of these cells [39]. The accumulation of MZ B cells in older p50-/- mice could reflect compensatory mechanisms in one or more of these signal transduction pathways important for the emergence or maintenance of MZ B cells. A fourth possibility is that the small numbers of MZ B cells that successfully emerge in p50-/- mice survive for extended periods of time, resulting in the slow accumulation of this subset of cells with age. Hao and Rajewsky [40] have demonstrated that the half-life of MZ B cells is greater than that of FO B cells. Thus, a simple explanation for the accumulation of MZ B cells in p50-/- mice with age is that these cells preferentially survive, and thus their frequency relative to the FO B cell pool and other B cells in the spleen increases slowly with age.
###end p 24
###begin p 25
###xml 16 20 16 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 225 229 225 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 551 555 551 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 663 667 663 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1620 1622 1616 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 1539 1543 <span type="species:ncbi:10090">mice</span>
B cells from p50-/- mice are compromised in their ability to respond to specific antigen challenge, and are completely unresponsive to mitogenic substances such as LPS [16]. However, our data suggests that MZ B cells from p50-/- mice display some functionality, including the binding, transport and deposition of IgM-IC onto FDCs, a function unique to MZ B cells [15]. Like IgM-containing T-dependent immune complexes, MZ B cells also bind T-independent type 2 (TI-2) antigens in a complement and CR1/2-dependent manner [41]. Despite the fact that p50-/- mice are widely considered to be devoid of MZ B cells, the presence of small numbers of these B cells in p50-/- mice were in fact noted in the initial studies of Pillai and colleagues, and these appeared to bind low levels of TI-2 antigens [17]. However, further analysis of the consequences of this binding, such as the transfer of immune complexes to FDCs, was not evaluated. The results of the current study not only extend these previous studies, but demonstrate that one consequence of the small amount of IgM-IC binding manifests itself by the limited, but none-the-less detectable, deposition of these complexes onto FDCs. This suggests that this function of MZ B cells is completely independent of the activation of NF-kappaB, at least those complexes containing p50. These results extend other evidence suggesting that the activation of MZ B cells through engagement of the BCR may not be required for transport and deposition of IgM-IC, since MZ B cells from CD19-deficient mice, which also have deficits in MZ B cells, are also functional in this assay [15].
###end p 25
###begin p 26
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 860 862 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
Together, these results raise the question of whether MZ B cells require activating signals to migrate into B cell follicles following IgM-IC binding to CR1/2. MZ B cell migration can be detected in 1 h or less after the binding of IgM-IC [15]. The binding of IgM-IC to these cells may interfere with one or more of the mechanisms proposed to play a role in MZ B cell positioning, including retention by macrophages within the MZ [42], integrin-mediated retention [39], or responsiveness to lysophospholipids in the blood [43]. Once released, the MZ B cells would be expected to migrate into follicles in response to chemoattractants such as BLC [44]. These considerations suggest that follicular migration of MZ B cells may be the "default" pathway, whereas BCR engagement, which is known to direct MZ B cells not into the follicles but to the T-B interface [45-47], actively alters the fate of antigen specific MZ cells away from follicular migration.
###end p 26
###begin p 27
###xml 68 72 68 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 486 490 486 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
Despite the increase in frequency (and numbers) of MZ B cells in p50-/- mice, the deposition of IgM-IC within the follicles does not improve with age, but declines severely. This appears to be due to a decrease in function of FDCs, which are fewer in number and are less pronounced, as evidenced by CD21 staining (Figure 5). Thus, the decreased ability of FDCs to retain complement containing immune complexes observed in old mice [27], appear to emerge with accelerated kinetics in p50-/- mice.
###end p 27
###begin p 28
###xml 173 175 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
NF-kappaB p50 is only one of a growing number of genes, including a number of transcription factors, whose expression influences the development of MZ B cells (reviewed in [48]), highlighting the complex interactions that must converge to generate this B cell compartment. The fact that the requirements for individual proteins, such as p50, could change with age suggests that compensatory mechanisms exist which can overcome cellular defects, and/or that more than one pathway to generate these cells may exist.
###end p 28
###begin title 29
Conclusion
###end title 29
###begin p 30
###xml 185 189 185 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 305 309 305 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 546 550 546 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 550 554 <span type="species:ncbi:10090">mice</span>
These experiments demonstrate the profound influence age can exert on cellular populations in genetically modified mice. The appearance of large numbers of MZ B cells in 6 month old p50-/- mice suggests that compensatory mechanisms overcome the deficits caused by p50-deficiency. Both in young and old p50-/- mice, these MZ B cells appear to retain some functionality, as assessed by their ability to bind, transport and deposit IgM-IC onto FDCs. On the other hand, FDCs are unable to maintain their functional capacity to trap IgM-IC in aged p50-/- mice indicating that, while MZ B cells recover with age, other immune defects become more pronounced as a result of deficiency in this member of the NF-kappaB family of transcription factors.
###end p 30
###begin title 31
Methods
###end title 31
###begin title 32
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 32
###begin p 33
###xml 52 58 48 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1Bal</sup>
###xml 61 63 57 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 129 133 <span type="species:ncbi:10090">Mice</span>
###xml 404 408 <span type="species:ncbi:10090">Mice</span>
C57BL/6J and NF-kappaB p50 deficient (B6;129P2-Nfkb1tm1Bal) [16] mice were purchased from Jackson Laboratories (Bar Harbor, ME). Mice were maintained in the Laboratory Animal Sciences Center, Boston University Medical Center. All studies were reviewed by an Institutional Animal Care and Use Committee and carried out in accordance with established guidelines according to National Institutes of Health. Mice of both sexes were used at 2 to 6 months of age as described.
###end p 33
###begin title 34
Preparation and injection of IgM-containing immune complexes (IgM-IC)
###end title 34
###begin p 35
###xml 65 67 64 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12</sub>
###xml 221 222 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 223 225 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were injected i.v. with a mixture of 15 to 20 mug each of NP12-BSA-biotin (Biosearch Technologies, Novato, CA) and affinity purified pentameric IgM anti-NP monoclonal antibody (B1-8) exactly as previously described [7,15].
###end p 35
###begin title 36
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
In vitro binding assay
###end title 36
###begin p 37
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 320 321 313 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 223 228 <span type="species:ncbi:10090">mouse</span>
In vitro assays to assess the binding of IgM-IC to MZ B cells were performed as previously described [15]. Briefly, IgM-IC were formed by mixing 1 mug each of NP-BSA-biotin and B1-8 IgM in RPMI in the presence of 10% fresh mouse serum as a source of complement and incubated for 30 minutes at 37degreesC. Splenocytes (107) were resuspended in the IgM-IC and incubated at 37degreesC for an additional 30 minutes. Cells were washed and analyzed by flow cytometry.
###end p 37
###begin title 38
Immunohistochemistry (IH)
###end title 38
###begin p 39
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 337 338 324 325 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 339 340 326 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 908 909 895 896 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 950 952 937 939 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12</sub>
###xml 1335 1336 1322 1323 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1337 1338 1324 1325 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1646 1647 1633 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 382 388 <span type="species:ncbi:9986">rabbit</span>
###xml 392 395 <span type="species:ncbi:10116">rat</span>
###xml 809 813 <span type="species:ncbi:9925">goat</span>
###xml 819 822 <span type="species:ncbi:10116">rat</span>
###xml 884 888 <span type="species:ncbi:9925">goat</span>
###xml 894 897 <span type="species:ncbi:10116">rat</span>
###xml 1220 1225 <span type="species:ncbi:9796">horse</span>
###xml 1226 1232 <span type="species:ncbi:3726">radish</span>
Staining of spleen sections was performed exactly as previously described [7,15]. Briefly, spleens were removed and snap frozen in O.C.T. Compound (Tissue Tek, Torrance, CA) and stored at -80degreesC. 6 mum sections were cut (IEC Microtome, Needham, MA) and fixed in acetone at -20degreesC for 10 min. Sections were incubated with 0.3% H2O2/PBS for 5 min and blocked with 3% normal rabbit or rat serum. All antibodies were diluted in 5% BSA in PBS. Primary antibodies used included: anti-CD3-FITC (1/200), anti-CD3-biotin (1/200), anti-CD21/35-FITC (1/100), (all from BD Biosciences, San Diego), ER-TR9 (1/200; BMA Biomedical, Augst, Switzerland), and anti-FDC-M2 (1/200; Immunokontact, Frankfurt, Germany). Secondary antibodies included anti-FITC-HRP (1/100; Roche Molecular Biochemicals, Indianapolis, IN), goat anti-rat IgG-HRP (1/500; Jackson Immunoresearch, West Grove, PA), and goat anti-rat IgM (Fab')2-HRP (1/1000; Jackson Immunoresearch). NP12-BSA-biotin and anti-CD3-biotin was visualized by alkaline phosphatase (AP)-streptavidin (1/400; Molecular Probes, Eugene, OR) and developed with napthol AS-MX phosphate/Fast blue BB base (Sigma, St. Louis, MO). Visualization of antibody stains was accomplished using horse radish peroxidase (HRP) conjugated secondary antibodies developed with 3-amino-9-ethylcarbazole (Sigma) and H202. After staining, sections were covered with crystal mount (Biomedia, Foster City, CA) before examining by digital microscopy (Zeiss, Axiovert 200 M, Oberkochen, Germany). Unless otherwise noted, all images were obtained using a 10x objective (initial magnification of 100x) unless otherwise noted (see Fig. 4).
###end p 39
###begin title 40
Immunofluorescence (IF)
###end title 40
###begin p 41
###xml 130 134 <span type="species:ncbi:9925">goat</span>
###xml 140 143 <span type="species:ncbi:10116">rat</span>
###xml 286 292 <span type="species:ncbi:9986">rabbit</span>
Sections were initially treated as for IH. Antibodies utilized included anti-MOMA-1 (1/25; Serotec, Raleigh NC) visualized with a goat anti-rat IgG-AMCA (1/100; Jackson Immunoresearch), anti-IgM-Texas Red (1/100; BD Biosciences), and anti-laminin (1/500; Sigma) visualized with an anti-rabbit IgG-FITC (1/100; Jackson Immunoresearch). All sections were covered with Fluoromount G (Jackson Immunoresearch) and a cover slip before examining by digital microscopy (Zeiss, Axiovert 200 M, Oberkochen, Germany).
###end p 41
###begin title 42
Flow cytometry
###end title 42
###begin p 43
###xml 522 524 522 524 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12</sub>
Splenocytes were isolated at the indicated times and stained as follows. The lymphocyte gate was utilized for all analysis. Cells were analyzed using a FACScan (Becton Dickinson, Franklin Lakes, NJ) and FlowJo software (Tree Star, Ashland, OR). Antibodies utilized were anti-B220-FITC (1/200), anti-B220-biotin (1/200), anti-B220-PE (1/200), anti-CD21/35-FITC (1/200), anti-CD23-PE (1/200), and anti-CD1d-FITC or PE (1/100) (BD Biosciences). Streptavidin-Cy5 (1/200; BD Biosciences) was used to identify the NP antigen (NP12-BSA-biotin) associated with lymphocytes, as well as to visualize biotin-labelled antibodies.
###end p 43
###begin title 44
Authors' contributions
###end title 44
###begin p 45
A.R.F. performed the experiments reported in this manuscript and participated in the data interpretation and analysis. R.B.C. originally conceived of the study, participated in data interpretation and analysis, and takes overall responsibility for the conduct of the studies. Both authors have read and approve of the final manuscript.
###end p 45
###begin title 46
Acknowledgements
###end title 46
###begin p 47
The authors would like to thank members of our laboratory for thoughtful discussions and K. Daley for critical reading of the manuscript. This work was supported by USPHS grant AI31209 from the National Institutes of Health, and the Aid for Cancer Research for instrumentation grants. A.R.F. was supported in part by NIH training grants AI07903 and HL007501.
###end p 47
###begin article-title 48
Competition of 19S and 7S antigen receptors in the regulation of the primary immune response
###end article-title 48
###begin article-title 49
The mechanism of antibody-induced stimulation and inhibition of the immune response
###end article-title 49
###begin article-title 50
###xml 50 55 <span type="species:ncbi:9940">sheep</span>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Antigen-dependent IgM-mediated enhancement of the sheep erythrocyte response in mice. Evidence for induction of B cells with specificities other than that of the injected antibodies
###end article-title 50
###begin article-title 51
###xml 48 54 <span type="species:ncbi:10090">murine</span>
Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination
###end article-title 51
###begin article-title 52
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Specific IgM enhances and IgG inhibits the induction of immunological memory in mice
###end article-title 52
###begin article-title 53
###xml 38 55 <span type="species:ncbi:10407">hepatitis B virus</span>
Enhancement of the immune response to hepatitis B virus vaccine by antigen specific IgM
###end article-title 53
###begin article-title 54
Synergistic roles of IgM and complement in antigen trapping and follicular localization
###end article-title 54
###begin article-title 55
Complement activation is required for IgM-mediated enhancement of the antibody response
###end article-title 55
###begin article-title 56
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Antibody production in mice deficient for complement receptors 1 and 2 can be induced by IgG/Ag and IgE/Ag, but not IgM/Ag complexes
###end article-title 56
###begin article-title 57
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in s ecreted IgM
###end article-title 57
###begin article-title 58
A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection
###end article-title 58
###begin article-title 59
Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response
###end article-title 59
###begin article-title 60
B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection
###end article-title 60
###begin article-title 61
Control of early viral and bacterial distribution and disease by natural antibodies
###end article-title 61
###begin article-title 62
Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells
###end article-title 62
###begin article-title 63
Targeted disruption of the p50 subunit of NF-kappaB leads to multifocal defects in immune responses
###end article-title 63
###begin article-title 64
Nuclear factor kappaB is required for the development of marginal zone B lymphocytes
###end article-title 64
###begin article-title 65
Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses
###end article-title 65
###begin article-title 66
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice
###end article-title 66
###begin article-title 67
CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: beta 2-microglobulin-dependent and independent forms
###end article-title 67
###begin article-title 68
CD1high B cells: a population of mixed origin
###end article-title 68
###begin article-title 69
Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation
###end article-title 69
###begin article-title 70
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Marginal metallophilic cells of the mouse spleen identified by a monoclonal antibody
###end article-title 70
###begin article-title 71
###xml 80 84 <span type="species:ncbi:10090">mice</span>
CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice
###end article-title 71
###begin article-title 72
Cells of the marginal zone of the spleen are lymphocytes derived from recirculating precursors
###end article-title 72
###begin article-title 73
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Selective malformation of the splenic white pulp border in L1-deficient mice
###end article-title 73
###begin article-title 74
Follicular dendritic cells in aging, a "bottle-neck" in the humoral immune response
###end article-title 74
###begin article-title 75
To 'B' or not to 'B' a germinal center?
###end article-title 75
###begin article-title 76
###xml 112 117 <span type="species:ncbi:10090">mouse</span>
The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues
###end article-title 76
###begin article-title 77
Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones
###end article-title 77
###begin article-title 78
Regulation of naive and memory T-cell homeostasis
###end article-title 78
###begin article-title 79
Naive B lymphocytes undergo homeostatic proliferation in response to B cell deficit
###end article-title 79
###begin article-title 80
Targets of B-cell antigen receptor signaling: the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway and the Rap1 GTPase
###end article-title 80
###begin article-title 81
Rel/NF-kappaB transcription factors: key mediators of B-cell activation
###end article-title 81
###begin article-title 82
Signalling pathways of the TNF superfamily: a double-edged sword
###end article-title 82
###begin article-title 83
The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21
###end article-title 83
###begin article-title 84
B cell receptor signal strength determines B cell fate
###end article-title 84
###begin article-title 85
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations
###end article-title 85
###begin article-title 86
Integrin-mediated long-term B cell retention in the splenic marginal zone
###end article-title 86
###begin article-title 87
Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow
###end article-title 87
###begin article-title 88
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response
###end article-title 88
###begin article-title 89
Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone
###end article-title 89
###begin article-title 90
Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone
###end article-title 90
###begin article-title 91
Follicular stromal cells and lymphocyte homing to follicles
###end article-title 91
###begin article-title 92
Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens
###end article-title 92
###begin article-title 93
Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens
###end article-title 93
###begin article-title 94
Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen
###end article-title 94
###begin article-title 95
Marginal-zone B cells
###end article-title 95
###begin title 96
Figures and Tables
###end title 96
###begin p 97
###xml 3 7 3 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">p50<sup>-/- </sup>mice trap IgM-IC less efficiently on FDCs. </bold>
###xml 85 89 85 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
p50-/- mice trap IgM-IC less efficiently on FDCs. Localization of IgM-IC in B6 or p50-/- mice was determined by IH 16 h after injection. ER-TR9 identifies marginal zone macrophages (MZM) and FDC-M2 identifies FDCs. IgM-IC (which appear blue in this and all subsequent figures and are identified by arrows) are localized to FDCs in spleens from both groups of mice, but FDCs from B6 mice show more intense staining, indicating that more IgM-IC are trapped in these mice. All IH stains were performed on serial sections and were developed side-by-side for identical periods of time.
###end p 97
###begin p 98
###xml 3 7 3 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">p50<sup>-/- </sup>mice contain reduced numbers of MZ B cells that bind high levels of IgM-IC </bold>
###xml 82 85 82 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. </bold>
###xml 146 150 146 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 427 431 427 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 618 621 618 621 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 621 630 621 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 772 776 772 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 832 835 832 835 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C. </bold>
###xml 879 882 879 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi </sup>
###xml 984 988 984 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1009 1011 1009 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 776 780 <span type="species:ncbi:10090">mice</span>
###xml 988 992 <span type="species:ncbi:10090">mice</span>
###xml 1132 1136 <span type="species:ncbi:10090">mice</span>
p50-/- mice contain reduced numbers of MZ B cells that bind high levels of IgM-IC A. B cell subsets and IgM-IC binding. Splenocytes from B6 or p50-/- mice were analyzed for B cell subsets by FACS using CD21/CD23 or B220/CD1d expression. Histograms on the right show binding of IgM-IC to MZ and FO B cells 1 h after i.v. injection (shaded region); clear profiles represent uninjected control mice. Although spleen cells from p50-/- mice contained reduced numbers of MZ B cells, the cells present in the MZ B cell gate bind IgM-IC at high levels over background, similar to levels of binding of IgM-IC to B6 MZ B cells. B. In vitro binding assay showing binding of IgM-IC to MZ B cells (shaded region) compared with FO B cells (clear region). MZ B cells from both B6 and p50-/- mice bind high levels of IgM-IC compared to FO B cells. C. Immunofluorescence shows the presence of IgMhi cells (red) in the MZ as demarcated by MOMA-1 (marginal metallophilic macrophages, blue) staining. p50-/- mice possess some IgM+ cells in the MZ outside of the MOMA-1 ring, consistent with the presence of appropriately positioned MZ B cells in these mice.
###end p 98
###begin p 99
###xml 3 7 3 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 96 0 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">p50<sup>-/- </sup>mice accumulate MZ B cells with age that have the capacity to bind high levels of IgM-IC </bold>
###xml 96 99 96 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. </bold>
###xml 168 172 168 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 250 254 250 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 306 310 306 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 348 351 348 351 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 351 360 351 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
p50-/- mice accumulate MZ B cells with age that have the capacity to bind high levels of IgM-IC A. FACS profile of splenocytes from 2 and 6 month old B6 and 6 month p50-/- mice reveal the presence of normal numbers of MZ B cells in spleens of the p50-/- mice. Histograms illustrate binding of IgM-IC to p50-/- MZ B cells as described in Figure 2A. B. In vitro IgM-IC binding assay. Binding to MZ B cells (shaded profiles); binding to FO B cells (clear profiles).
###end p 99
###begin p 100
###xml 57 61 57 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phenotypic and histological analysis of MZ B cells in p50<sup>-/- </sup>mice </bold>
###xml 66 69 66 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. </bold>
###xml 142 146 142 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 196 199 196 199 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 373 377 373 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 457 460 457 460 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C. </bold>
###xml 490 493 490 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi </sup>
###xml 612 616 612 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
Phenotypic and histological analysis of MZ B cells in p50-/- mice A. FACS profile of splenocytes from 2 and 6 month old B6 and 6 month old p50-/- mice revealed by B220/CD1d and B220/CD9 profiles. B. FACS histograms showing IgM levels on MZ and FO B cells (shaded and clear regions, respectively) as determined by CD21/23 profiles. Cells present in the MZ B cell gate in p50-/- mice express higher levels of IgM compared with FO B cells, similar to B6 mice. C. IF reveals well demarcated IgMhi cells (in red) in the MZ outside of the laminin staining (which identifies the marginal sinus; in green) in 6 month p50-/- mice.
###end p 100
###begin p 101
###xml 29 33 29 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Deteriorated FDCs in aged p50<sup>-/- </sup>mice correlates with reduced IgM-IC localization </bold>
###xml 82 85 82 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. </bold>
###xml 136 140 136 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 332 336 332 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 342 345 342 345 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 428 432 428 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 614 618 614 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
Deteriorated FDCs in aged p50-/- mice correlates with reduced IgM-IC localization A. 2 month and 6 month old B6 mice and 6 month old p50-/- mice were injected with IgM-IC and analyzed by IH for IgM-IC localization 16 h later. IgM-IC were present on FDCs in 2 and 6 month B6 mice (see arrows), but were not deposited onto FDCs in p50-/- mice. B. Intense CD21 staining (designated by arrows) was less visible in the spleens of p50-/- mice, indicating that FDC networks were poorly developed in these mice. This suggests that reduced IgM-IC localization may be attributed to the loss of functional FDC networks in p50-/- mice. The magnifications noted refer to the objective used, not the absolute magnification.
###end p 101

